Emily Pimblett - 18 Jun 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Reporting relationship: SVP, Finance & CAO
Issuer ticker: CLYM
Reported as of: 18 Jun 2025
Net transaction value: -$1,540
SEC form: 4
Accepted by SEC: 20 Jun 2025, 16:20:04 UTC
Prior SEC filing: 20 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Emily Pimblett

Key filing fact

Emily Pimblett filed Form 4 for Climb Bio, Inc. (CLYM) on 20 Jun 2025.

Key facts

This page summarizes Emily Pimblett's Form 4 filing for Climb Bio, Inc. (CLYM).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Jun 2025, 16:20.

Change

Previous filing in this sequence was filed on 20 Mar 2025.
Current net transaction value: -$1,540.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001969365 Primary reporting owner

Pimblett Emily

Relationship: SVP, Finance & CAO
Address: C/O CLIMB BIO, INC., 20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS
Signature: /s/ Emily Pimblett
Signature date: 20 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLYM transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,000
Change %: +33%
Price
Shares after: 20,130
Date: 18 Jun 2025
Ownership: Direct
Footnotes: F1

CLYM transaction

Common Stock

Sale

Transaction value: $1,540
Shares: -1,242
Change %: -6.2%
Price: $1.24
Shares after: 18,888
Date: 20 Jun 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLYM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -5,000
Change %: -25%
Price: $0.000000
Shares after: 15,000
Date: 18 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Emily Pimblett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.

Footnote F2

The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.

Footnote F3

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F4

The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.